Product Information
PROPOFOL 200 MG/20 ML VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $0.1709 per ML under NDC 25021060820. Its NADAC has been published 107 times since Jun 19, 2024.
FDA first approved this application on Jan 4, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/mL
Manufacturer
Sagent PharmaceuticalsNDC
25021060820
Classification
Generic
Dosage Form
INJECTION, EMULSION
Route
INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
PROPOFOLApproval Type
Generic (ANDA)
FDA Application
ANDA075102FDA Approved
1/4/1999
TE Code
AB
On Market Since
7/1/2014
Pharmacological Classes
Price Statistics
The NADAC for PROPOFOL 200 MG/20 ML VIAL has been published 107 times since Jun 19, 2024, and over the history we have for it it has risen 15.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1709 per ML |
|---|---|
| All-time high | $0.1750 (Jun 10, 2026) |
| All-time low | $0.1384 (Nov 20, 2024) |
| 52-week high | $0.1750 |
| 52-week low | $0.1384 |
| Median price | $0.1384 |
| Average price | $0.1472 |
| Largest weekly change | +26.5% (Apr 22, 2026) |
| Weeks tracked | 107 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the propofol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
propofol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
General Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROPOFOL 200 MG/20 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for PROPOFOL 200 MG/20 ML VIAL, manufactured by Sagent Pharmaceuticals, is $0.1709 per ML (NDC 25021060820), effective Sep 30, 2026.
How has the price of PROPOFOL 200 MG/20 ML VIAL changed over time?
Over the history we have for it, the NADAC for PROPOFOL 200 MG/20 ML VIAL has risen 15.2%. It has been tracked across 107 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for PROPOFOL 200 MG/20 ML VIAL?
Since Jun 19, 2024, the NADAC for PROPOFOL 200 MG/20 ML VIAL has ranged from a low of $0.1384 (Nov 20, 2024) to a high of $0.1750 (Jun 10, 2026), with a median of $0.1384 per ML.
Are there cheaper alternatives to PROPOFOL 200 MG/20 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of PROPOFOL 200 MG/20 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROPOFOL 200 MG/20 ML VIAL?
PROPOFOL 200 MG/20 ML VIAL (NDC 25021060820) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.